2003
DOI: 10.1016/s1053-2498(02)00803-3
|View full text |Cite
|
Sign up to set email alerts
|

Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

9
84
0
5

Year Published

2007
2007
2018
2018

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 107 publications
(98 citation statements)
references
References 4 publications
9
84
0
5
Order By: Relevance
“…Given the limited number of available donor hearts, the long-term results of this treatment option need to be evaluated. In this systematic review and meta-analysis, the three major indications for heart RTx (coronary allograft vasculopathy, early graft failure and acute rejection) mirror those seen in other heart RTx experiences (20,23). We demonstrate that patients who underwent RTx had a significantly lower survival than those who only underwent primary HTx, principally due to a high early mortality amongst RTx patients.…”
Section: Discussionmentioning
confidence: 71%
See 3 more Smart Citations
“…Given the limited number of available donor hearts, the long-term results of this treatment option need to be evaluated. In this systematic review and meta-analysis, the three major indications for heart RTx (coronary allograft vasculopathy, early graft failure and acute rejection) mirror those seen in other heart RTx experiences (20,23). We demonstrate that patients who underwent RTx had a significantly lower survival than those who only underwent primary HTx, principally due to a high early mortality amongst RTx patients.…”
Section: Discussionmentioning
confidence: 71%
“…An early study of RTx at 13 centers revealed a 1-year survival of only 60% (17). Another study reporting on the outcomes from the Cardiac Transplant Research Database of 106 RTx recipients also confirm that survival after RTx was inferior to primary HTx with a survival of 56% at 1 year and 38% at 5 years (20).…”
Section: Discussionmentioning
confidence: 85%
See 2 more Smart Citations
“…2,5,14 Retransplantation remains the last therapeutic option for cardiac allograft failure due to progressive CAV. [31][32][33][34][35] Unfortunately, this therapeutic option is limited mostly because of organ shortage and associated with long waiting times. 36 Therefore, bridge to retransplantation and bridge to destination with a ventricular assist device might be lifesaving.…”
mentioning
confidence: 99%